These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20709388)

  • 21. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.
    Lapidus RG; Dang W; Rosen DM; Gady AM; Zabelinka Y; O'Meally R; DeWeese TL; Denmeade SR
    Prostate; 2004 Feb; 58(3):291-8. PubMed ID: 14743469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
    Son MJ; Song HS; Kim MH; Kim JT; Kang CM; Jeon JW; Park SY; Kim YJ; Groves MD; Park K; Kim JH; Nam DH
    Int J Oncol; 2006 Jun; 28(6):1385-92. PubMed ID: 16685440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
    Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
    Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
    Chun C; Lee SM; Kim SY; Yang HK; Song SC
    Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
    Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
    El Hilali N; Rubio N; Blanco J
    Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors.
    Song S; Yu B; Wei Y; Wientjes MG; Au JL
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6058-65. PubMed ID: 15447990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug.
    Ahmed F; Pakunlu RI; Brannan A; Bates F; Minko T; Discher DE
    J Control Release; 2006 Nov; 116(2):150-8. PubMed ID: 16942814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
    Xie M; Zhou L; Hu T; Yao M
    Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
    Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
    J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
    Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.
    Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS
    Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
    Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and preliminary characterization of concentric multi-walled chitosan microspheres.
    Chang SJ; Niu GC; Kuo SM; Chen SF
    J Biomed Mater Res A; 2007 Jun; 81(3):554-66. PubMed ID: 17133452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres.
    Gupte A; Ciftci K
    Int J Pharm; 2004 May; 276(1-2):93-106. PubMed ID: 15113618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor.
    Joo KM; Park K; Kong DS; Song SY; Kim MH; Lee GS; Kim MS; Nam DH
    Oncol Rep; 2008 Jan; 19(1):17-23. PubMed ID: 18097571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
    Elkharraz K; Faisant N; Guse C; Siepmann F; Arica-Yegin B; Oger JM; Gust R; Goepferich A; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):127-36. PubMed ID: 16490330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.